Cinaport and Fire & Flower Complete $36.5 Million Financing and the Reverse Takeover of Cinaport Acquisition Corp.
On November 2. 2018, Cinaport Acquisition Corp. II (TSXV: CPQ.P) ("Cinaport" or the "Company"), a capital pool company listed on the TSX Venture Exchange (the "Exchange"), and Fire & Flower Inc. ("Fire & Flower"), an independent retail chain that offers cannabis products and accessories, announced that Fire & Flower completed the private placement in connection with the reverse takeover of the Company by Fire & Flower (the "Qualifying Transaction").
The Private Placement was made through a syndicate of agents, led by GMP Securities L.P. and AltaCorp Capital Inc., and included Clarus Securities Inc., Echelon Wealth Partners Inc. and Eight Capital (collectively, the "Agents"). Pursuant to the Private Placement, Fire & Flower issued 24,333,334 subscription receipts (the "Subscription Receipts") at a price of $1.50 per Subscription Receipt for aggregate gross proceeds of $36,500,001.
The Private Placement was completed in connection with the Qualifying Transaction between the Company and Fire & Flower. Subject to approval by the Exchange, the Qualifying Transaction will be completed by way of a three-cornered amalgamation whereby Fire & Flower will amalgamate with 11048449 Canada Inc., a wholly-owned subsidiary of the Company. Upon satisfaction of the Escrow Release Conditions, each Subscription Receipt will be automatically exchanged, without payment of any additional consideration, for one common share of Fire & Flower, which will subsequently be exchanged for one Resulting Issuer Share pursuant to the terms of the Qualifying Transaction. In addition, the Compensation Options will also be exchanged for equivalent instruments of the Resulting Issuer exercisable for Resulting Issuer Shares.
The net proceeds raised from the Private Placement will be used by Fire & Flower for capital expenditures, working capital and general corporate purposes.
Expertise
Featured Work
-
Cannabis
Organigram acquires Sanity Group
Goodmans LLP advised Organigram Global Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, in connection with its acquisition of Sanity Group GmbH (“Sanity” or “Sanity… -
Cannabis
Organigram Holdings Inc. receives $124 million investment from BT DE Investments Inc.
Goodmans LLP advised Organigram Holdings Inc., the parent company of Organigram Inc., a leading licensed producer of cannabis, in connection with its C$124.6 million follow-on strategic equity… -
Restructuring
Ayr Wellness cross-border restructuring
Goodmans LLP acted as Canadian counsel to the Ad Hoc Committee Senior Noteholders of Ayr Wellness Inc. and Ayr Wellness Canada Holdings Inc. in connection with the negotiation and structuring of the… -
Restructuring
Wayland Group CCAA restructuring
Goodmans LLP represented the senior creditors in connection with the CCAA restructuring of Wayland Group and the acquisition of its operating business by Ring… -
Restructuring
MJardin’s restructuring proceedings
Goodmans LLP acted for KSV Restructuring Inc. (“KSV”) in respect of MJardin Group, Inc. (“MJardin” or the “Company”), a publicly traded licensed Canadian cannabis producer, in its restructuring… -
Capital Markets
Medicine Man Technologies NEO Listing
Goodmans LLP acted for Medicine Man Technologies, Inc., dba Schwazze (OTCQX: SHWZ) (NEO: SHWZ) in connection with their listing of common shares on the NEO Exchange – a tier one Canadian stock…